Author Archive

Suicidal & Homicidal Lyme Concerns Podcast

https://danielcameronmd.com/suicidal-and-homicidal-lyme-concerns/

SUICIDAL AND HOMICIDAL LYME CONCERNS

Suicidal and homicidal Lyme concerns

Welcome to another selection from my book “An Expert’s Guide on Navigating Lyme disease.” The books highlights the findings of my first 600 Lyme disease Science blogs.  In this episode, I will discuss suicidal and homicidal concerns in Lyme disease patients.

By 

Dr. Robert Bransfield from Rutgers-Robert Woods Johnson Medical School, Department of Psychiatry, has described suicidal and homicidal concerns in patients with Lyme and related tick-borne illnesses in his private practice. Likewise, in my practice I have seen patients with suicidal thinking.

SUICIDAL AND HOMICIDAL BEHAVIORS IN LYME DISEASE.

Dr. Robert Bransfield reports observing suicidal and homicidal behaviors in patients with Lyme and related tick-borne illnesses. Out of 253 patients, he found:

43% were suicidal; 32% were suicidal but not homicidal; 11% were both suicidal and homicidal. No patient was homicidal without also being suicidal. 25% had explosive anger but were not homicidal or suicidal. 10% had pre-existing depression. 97% reported depression after infection. Patients were ill an average of 8.4 years before being diagnosed and treated. Read more.

“Further disease progression contributed to him feeling desperate as a result of multiple late-stage symptoms.”

THREE PSYCHIATRISTS SHARE SUICIDAL AND HOMICIDAL CASES.

Three psychiatrists share published case reports supporting Bransfield’s concerns (Munir et al., 2017). “A 44-year-old male without any past psychiatric history presented with a third unsuccessful suicide attempt and was later diagnosed as having a Borrelia infection” (Bransfield, 2017). One month of medical therapy with intravenous ceftriaxone improved his mental status and resolution of suicidal ideation (Banerjee 2013).

Fallon described two cases in a 1995 paper. “I treated both of these patients, and in addition, I have been able to follow the status of Patient B over a span of 30 years. This patient was highly suicidal, had horrific intrusive images of killing others, and had violent impulses, which were eliminated with treatment. Patient A was also suicidal, violent, and physically assaultive to her son. Combined antibiotic and psychotropic treatment helped both patients.” Read more.

HOMICIDE, TWO ASSAULTS, AND SUICIDE IN LYME DISEASE PATIENT

An article entitled “A Fatal Case of Late Stage Lyme Borreliosis and Substance Abuse,” describes a patient exhibiting aggressiveness, violence, and homicidality. Like many Lyme disease patients, the man experienced a delay in diagnosis and treatment. (One study reports that subjects enrolling in a trial of Lyme encephalopathy were ill an average of two years before being diagnosed.)

The patient’s Lyme disease symptoms progressed. “Further disease progression contributed to him feeling desperate as a result of multiple late-stage symptoms,” wrote Bransfield et al.  According to Fallon et al., the number of Lyme disease patients who feel desperate is not clear.

Based on more than 30 years of experience treating Lyme disease patients, Dr. Bransfield previously described a wide range of neuropsychiatric symptoms in Lyme disease patients. “… neuropsychiatric symptoms, usually presenting with significant comorbidity which may include developmental disorders, autism spectrum disorders, schizoaffective disorders, bipolar disorder, depression, anxiety disorders (panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder, intrusive symptoms), eating disorders, decreased libido, sleep disorders, addiction, opioid addiction, cognitive impairments, dementia, seizure disorders, suicide, violence, anhedonia, depersonalization, dissociative episodes, derealization and other impairments.”

“A 44-year-old male without any past psychiatric history presented with a third unsuccessful suicide attempt and was later diagnosed as having a Borrelia infection.”

The patient’s condition worsened.  “The pathophysiological effects of the infection resulted in an increased number and severity of multisystem symptoms, disability, and substance abuse,” the authors wrote. “He experimented with multiple substances in an effort for relief.”

The authors added, “During acute deterioration of his mental state from phencyclidine withdrawal, NMDA agonism increased, he committed a homicide, two assaults, and suicide.”

In an earlier study, Dr. Bransfield described substance abuse, cannabis use, and intoxication in Lyme disease patients.

Bransfield and colleagues advised prompt diagnosis and treatment of Lyme disease to help prevent addictive disorders, substance abuse, and death.

“More effective diagnosis and treatment and attention to substance abuse potential in these patients may help prevent some cases of addictive disorders, substance abuse, and death.” Read more.

988 Suicide & Crisis Lifeline

The 988 Suicide & Crisis Lifeline is a national network of local crisis centers that provides free and confidential emotional support to people 24 hours a day, 7 days a week in the United States. Anyone with the following concerns can call, text, or chat 988:

  • Mental health-related distress.
  • Thoughts of suicide.
  • Substance use crisis.
  • Emotional distress.
  • There are specialized services available for veterans, LGBTQ individuals and other groups.
  • People who are worried about a loved one who may need support also can call.
The 988 Suicide & Crisis Lifeline, available by simply dialing 988, is a 24-hour, toll-free, confidential suicide prevention helpline available to anyone in suicidal crisis or emotional distress. When someone calls the helpline, his or her call is routed to the nearest crisis center. The Lifeline’s national network, consisting of more than 250 local crisis centers, provides crisis counseling and mental health referrals day and night.
Related Articles:

Mental health in COVID-19 and Lyme disease patients

Lyme disease and depression

Lyme disease patients at risk for suicide

Category:

Lyme, Psychological Aspects, research

The Age of Graphene (Must Read)

https://worldcouncilforhealth.substack.com/p/age-of-graphene

The Age of Graphene: Billion-Dollar Dreams

Is graphene safe? Has it really been found in Covid-19 injectables? Could this be why some people were magnetic on the area of their injection site? Let’s take a look at the evidence.

WORLD COUNCIL FOR HEALTH
AUG 1, 2023

By Francesca Havens, DPan

Graphene oxide, or reduced graphene oxide (GO/rGO) has been the topic of much research, much use and many controversies since it was invented less than two decades ago.

Most people had not, a few years ago, heard of any of the things that are now common parlance, like PEG, lipid nanoparticles and even less of GO. Yet now, men and women in their millions, some would say billions, go to sleep at night with the dark, electric angel of graphene cradling their dreams. How so you may ask, if this is yet new to you?

The most powerful controversies are happening right now in the midst of this paradigm-changing prolonged health crisis that some are calling the ever-giving gift: the pandemic. If we are to believe the evidence from the European Union’s €1 billion Graphene Flagship project, running now since 2013, and the industry go-to website graphene-info.com, GO is in absolutely everything! It is in anything from batteries to sanitary pads, from sensing ink for biomedical applications to nasal vaccines, from water filters to DNA sequencing, from tennis rackets to car parts and electronics. It can self-assemble in response to changes in temperature, and also with changes in ambient electromagnetic frequencies. Discovered in 2004, it is used in larger-scale assemblies all the way down to self-assembling nanotubes.

It is said to be 200 times stronger than steel, as well as being an excellent conductor of heat and electricity, very magnetic and with excellent light absorption qualities, which makes it understandably highly sought after in just about every industry.

THE OBVIOUS QUESTION: IS GRAPHENE SAFE?

Toxicology studies have accompanied the exponential growth of the industry, without fail pointing to the need for more research before it is used ubiquitously in every field and in forms that can evidentially penetrate to any part of the human body, including the brain.

Various academics and researchers have further indicated through RAMAN spectroscopy electron microscope techniques that graphene is present in the Covid-19 injectables, starting in 2021 with chemist Dr Pablo Campra of Almeria University, backed by many others (Zeee Media 2022, Austrian Pathologists 2021, Biscardi 2021, Botha 2021, Burkhardt 2021, Cipelli 2022, Delgado Martin 2022, Deruelle 2022, Exposé News 2023, Gazzeri 2022,  Giovannini 2022, Google Patents 2023, Hugues 2022, Iturriga 2021, Lee 2022, Madej 2021, Milhacea 2023, Monteverdi 2022, Nagase 2022, Nixon 2022, Noack 2021, Reissner 2021, Smith 2022, Van Welbergen 2022, Verkerk 2021, Wagh 2022, Wakeling 2022, Yanowitz 2022, Young 2021, Zalewski 2021).

Further to this, there is evidence that graphene is used in hydrogels (see nasal swabs above) and masks, so whichever way the human animal turns, there is a graphene trap.

GRAPHENE & THE INTERNET OF NANOTHINGS

There has been no public consultation that I know of towards the creation of human-machine interfaces, yet there is ample research that looks into just that:

“Bio-inspired molecular communications (MC), where molecules are used to transfer information, is the most promising technique to realise the Internet of Nano Things (IoNT), thanks to its inherent biocompatibility, energy-efficiency, and reliability in physiologically-relevant environments”.

The main difficulty with such nano communications seems to have been the electrically and magnetically conducive qualities of materials when used in biological systems, and graphene is the perfect solution. Note that in many studies they do not refer to the reality of living men, women and children or any other sentient being due to have technology implanted with or without consent: the language is always oblique and refers to ‘biocompatibility’ or ‘molecular communications’ or ‘physiologically-relevant’, yet we are clearly talking about human bodies. Other studies that focus with more clarity on certain biological functions like drug-delivery for cancer do acknowledge that it is the human body or its cells being targeted.

Naturally, there are many applications for these materials and nanotechnological systems that seem quite laudable, like applying them precisely to drug delivery to improve patient outcomes, or as scaffolding for tissues to enhance healing, nobody can argue with that. The doubt, however, that these rapidly developing technologies can be turned to darker purposes has been examined by numerous researchers, as above.

However, the decided lack of congruency and lack of science underpinning the synchronised transglobal governmental decisions right the way through the pandemic was so flagrant that those researchers and scientists that feared more for the wellbeing of humankind than for their own careers, income or reputations, turned to research to elucidate what could possibly have gone wrong.

Some were doctors who noted the crossover between their electrosensitive patients and those coming in with ‘Covid’ symptoms, where further research noted that the cases all came from an area where a mobile phone mast was erected. Further collaborative research revealed that elderly in 273 Spanish nursing homes curiously have mobile antennas directly outside their residences. Yet others refer to the magnetism shown by people, in thousands upon thousands of social media posts, on the area of their injection site or even on their chests, backs or foreheads. Of course the government, industry and think-tank sponsored ‘fact’ checkers all deny this phenomenon. Doth the industry protest too much? There are full conferences given over to the detection of graphene, and endless industrial suppliers of the same to be able to carry out these comparisons. There are even medical doctor-made documentaries claiming to show the phenomenon of undeclared MAC addresses coming from people, and even dead people (2021 onwards) in graveyards!

THE GRAPHENE ‘CORONA’

Information from Graphene Info explains that the human body treats graphene in the same manner it would a pathogen, calling on the rising suspicion that a graphene-radiation interface would be provoking what seemed to be a respiratory infection, as Dr Sevillano suspected on investigation into the geographical area his patients fell under (see above). This is during a time when the virus underlying the pandemic declared by the WHO remained unobtainable and undetected by any government, health department or institution questioned through freedom of information requests. Is it possible that graphene is magnified by the EMF emitted by mobile phone antennas? What about researchers who stated their research demonstrated no evidence of life or live matter in the coronavirus injectable vials? All graphene research in biotechnology is aimed at introducing it into the body one way or another, for multiple purposes, mostly obscure to ordinary people. However, I would not go from here to deride or underestimate the research done by esteemed virologists like Professor Montagnier, who alerted the public to the presence of HIV virus and other unusual viral sequences in the injectables. This is why I find it so confusing.

Once in the body, graphene attracts a web or crown of inflammatory proteins to deal with it and, in another remarkable coincidence, this bears an uncanny resemblance to the crown of the coronavirus so often depicted by the mainstream media and health authorities. The article linked further describes how “‘stealth’ NPs were developed by coating them with the hydrophilic polymer PEG” to dodge the immune system. The same article refers to the burgeoning number of research articles devoted to the phenomena of nanoparticle-provoked protein coronas and how to engage with them, in one way or another.

GRAPHENE & CHITOSAN, ANOTHER ELECTROMAGNETIC PROBLEM

As if the rest were not confusing enough, and has not created huge divides and inconsistencies even amongst scientists and commentators who are seemingly there for humanity and the Hippocratic oath, and not their wallets, there is yet another mind-boggling connection that is little investigated: the link between the functionality of graphene in all the applications mentioned, and further with chitosan, the carbon-rich insect exoskeleton extract. Again, this highly technical, combined nanomaterial is being hailed as a novel solution for health sciences. However, there are researchers that are questioning the potential uses in this field too, with extensive references.

Due to the number of incredible coincidences, onlookers are beginning to question the relationship between the triangle of injectible/intranasal modified nanoparticle drug delivery, the rapid expansion of the 5G network, and the insect diet being heavily promoted by supranational bodies down to primary schools (see “Insects on the menu” in this Substack). There is a little-elucidated query over the affinity between chitin and graphene, which some studies do suggest have natural affinity. Could it be that an insect-rich diet with non-disclosed graphene delivery from any of the potential fields of technology, including medicine, aviation fuel, and plant growth, would combine with the chitin automatically, enhancing the graphene within the body, thereby the potential as a sensor being used to gather or transmit information?

I consider the amount of research ordinary people have had to do in the last three years to keep abreast of developments and study hitherto-unknown areas of technology and medicine to be worthy of a Doctorate, indeed, why not DPan? Like the rest of my fellow pandemic graduates, I regard this collision and collusion of these different areas of technology, advancing at the speed of light with no consultation from ordinary men and women as to whether they choose this degree of complexity and intrusion into their bodies, families and lives, to be unconscionable. It calls for awareness, further research and consideration. Have you looked at the evidence, and what do you think?

Disclaimer: The views expressed in this article are Francesca’s own and do not necessarily represent the World Council for Health.

Please share this important post!

(Please see top link for an extensive list of references)

________________

See this important video on why Nano Graphene is the Most Destructive Technology Ever Invented.  (Approx. 12 Min)

For more:

Category:

Activism, vaccines, Viruses

ACTION ALERT: FDA Trying to Ban CBD

https://www.paintreatmentdirectory.com/posts/the-fda-is-trying-to-ban-cbd-supplements

The FDA is Trying to Ban CBD Supplements

The FDA is Trying to Ban CBD Supplements

By: ANH-USA

Editor’s note: The following article and call to action about the FDA’s efforts to ban CBD supplements is being reprinted from the Alliance for Natural Health website. This is not the first time the FDA has tried banning natural treatments relied on by millions of Americans, but part of a long and corrupt history. The FDA has also been trying for several years to ban kratom, an herb being successfully used by millions of Americans to treat pain, opioid addiction and withdrawal, anxiety and more. Recently, the FDA has also taken action against homeopathy, a safe, natural system of medicine used worldwide since its development in 1810. The FDA has been trying to get stronger regulatory authority to take vitamins and other supplements off the market. It seems the FDA is leaving no stone unturned in its efforts to protect the profits of the pharmaceutical industry instead of protecting the health of the public.

The FDA Misleads on CBD Safety

…providing further evidence that the agency is trying to engineer a ban on affordable CBD to protect drug industry profits. Action Alert!

As the evidence of CBD’s myriad health benefits continues to pile up, it increasingly looks to us like the FDA is preparing to issue a ban on CBD supplements. We must support bills in Congress that take the issue out of the FDA’s hands by allowing the sale of CBD in supplement form.

Lawmakers do appear to be taking this issue seriously. In addition to the bill introduced by Representative Morgan Griffith (R-VA), another similar bill has just been introduced by Senators Ron Wyden (D-OR), Rand Paul (R-KY), Jeff Merkley (D-OR), and Representative Earl Blumenauer (D-OR) to allow the sale of CBD in supplements. Additionally, Congress is holding a hearing on July 27 during which members will formally scrutinize the impact of the FDA’s failure to develop a regulatory pathway for the sale of CBD in supplements and food. Let’s show the FDA the scale of our opposition to its unjustified plan and demonstrate the huge level of grassroots support for CBD supplements ahead of the hearing.

We want to make it crystal clear what we face if we don’t stop the FDA in its tracks. CBD, or cannabidiol, is one of over 100 natural compounds called cannabinoids found in a wide range of plants, most notably the hemp plant. The cells of our bodies are laced with cannabinoid receptors that form part of the endocannabinoid system that is essential to life and to robust health. We produce cannabinoids internally (endocannabinoids) and we also consume them in some foods (exocannabinoids). Most of these cannabinoids, including CBD, are not psychoactive – THC being an exception – but they all offer profound benefits. CBD is one of the most well researched non-psychoactive cannabinoids and it has an incredible array of health benefits, with evidence showing that has profound anti-inflammatory and immune modulating effects and can help with pain, anxiety, depression, certain cancers, and even heart health.

Let that sink in for a moment. The opioid epidemic is killing an astonishing number of Americans every year; rates of anxiety and depression are reaching new highs, particularly among young people; heart disease is the leading cause of death for adults in the US. CBD has been found to help with all of these conditions, but instead of working to make this compound more widely available as a supplement, which is the way it should be sold according to the Dietary Supplement and Health Education Act of 1994 (DSHEA), the FDA wants to stop all supplement sales of CBD. The FDA’s justification is the protection of the profits of one pharmaceutical company that has a CBD drug that will cost patients a stunning $32,500 per year. It will also mean citizens who have been benefiting from low-cost health support from CBD supplements since they became widely available a few years ago will have no further access to the supplements they have relied on. There is something deeply wrong with this picture.

How did we get here? For starters, the FDA says that CBD can’t be a supplement because it has approved a drug version of CBD called Epidiolex that is used to treat two rare forms of epileptic seizure, Lennox-Gastaut syndrome (LGS) or Dravet syndrome, in children over 2 years. This ability for FDA to rule in favor of drug companies has to do with the FDA back-channel that we’ve written about many times before. In short, if a substance is studied as a drug (i.e. a drug company has made an Investigational New Drug application) before there is evidence it was sold as a supplement (i.e. evidenced by a supplement company’s New Dietary Ingredient notification), then the drug company can ask the FDA to ban the supplement form of that compound.

Yet, as pressure mounts from Congress and a variety of stakeholders to make CBD more widely available, the FDA has been reviewing scientific information on CBD. Earlier this year, the agency released a statement explaining that the “existing regulatory framework” for foods and supplements is not appropriate for CBD and that a new regulatory pathway is needed.

One of the main issues raised by the FDA is that of safety. The agency claims that CBD presents various safety concerns, specifically the potential for harm to the liver and the reproductive system and concerns for vulnerable populations such as children and pregnant women.

These views are articulated in a review article authored in part by FDA staff. To support the assertion that CBD can pose threats to the male reproductive system, the authors cite a 1981 animal study in which monkeys were administered 30, 100, or 300 milligrams per kilogram of body weight per day (mg per kg bw/day) of CBD orally. But consider that 300 mg per kg bw/day for a human weighing 154 pounds would be 21,000 mg, or 21g, of CBD—far, far more than anyone would ever take as a supplement!

This is emblematic of a larger problem we’ve discussed before: the deeply flawed risk assessment models used by federal bureaucrats to prevent us from utilizing natural medicines to stay healthy. These types of models have been used by European regulators to set absurd limits on supplement dosages (known as tolerable upper limits, or ULs). ANH’s founder and Executive and Scientific Director, Robert Verkerk, PhD, has published several papers critiquing this approach that was originally developed by the Institute of Medicine (now the National Academy of Medicine), pointing to a fundamental flaw: in trying to restrict vitamin or other micronutrient dosages in this way, regulators completely ignore the fact that risks vary greatly depending on the form and dose of a nutrient used, and for most populations you’ll find overlap in the doses that cause health benefits for the majority and risks for a few. So if you then create a law that aims to eliminate a potential risk for everyone, you actually deprive the vast majority access to the micronutrient and all the benefits it offers.

Bringing it back to CBD: the fact that the FDA is, in part, using a decades-old animal study in which an absurdly high CBD dose was used to demonstrate that CBD has safety concerns once again demonstrates that the federal approach to assessing risk and benefit is fundamentally broken. It’s based on a defunct toxicological model that should have no place in modern day food or supplement law-making. The agency is also not giving proper weight to the incredibly favorable safety record of CBD used as a supplement or the multitude of benefits we can get from using CBD as a supplement. Instead, the FDA has chosen to focus on old evidence of harm that was only found when absurdly high doses were taken experimentally. To us, it seems like the agency is simply grasping at any information it can to demonstrate harm so it can justify its proposed ban on CBD supplements. The driver? Nothing less than preventing competition for the pharmaceutical drug version of CBD, given its the drug companies that are the FDA’s principal paymasters.

And, indeed, the FDA’s view on CBD’s safety is not supported by experts in the industry and elsewhere. A 2020 meta-analysis looked at human trials to assess CBD efficacy and safety. The authors concluded that most studies reported no adverse events with acute administration of CBD and mild to moderate effects with chronic administration, with the most common side effects being tiredness, diarrhea and changes of appetite/weight. Again, these side effects must be weighed against the benefits of CBD use for combatting opioid misuse, heart disease, anxiety, and depression. Harvard Health Publishing, the publication of the Harvard Medical School, states simply that, for adults, “CBD appears to be very safe.”

We cannot allow the FDA to cater to the drug industry at the expense of public health.

Action Alert! Write to Congress in support of bills that allow the legal sale of CBD in supplements. Please send your message immediately.

The FDA has said that they will not be allowing CBD to be in food or supplements, explaining that the “existing regulatory framework” for foods and supplements are not appropriate for CBD. The agency denied three Citizens Petitions requesting the agency issue a regulation that would allow CBD to be sold as a supplement. Clearly the FDA is more interested in protecting Big Pharma profits than with promoting consumer access to a product that can benefit their health. We need Congress to take the issue out of the FDA’s hands to create a legal pathway for CBD supplements.

Write to Congress and tell them to support the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 and the Hemp Access and Consumer Safety Act to protect access to CBD supplements.

Sign the Petition Here

_________________

**Comment**

The FDA wants patients between a rock and a hard place.  On one hand they state extended antibiotics are not to be used for Lyme/MSIDS because they are unsafe, and then they also want to remove important supplements that help us, but when the agency is alerted to the fact doctors have never witnessed so many “vaccine”-related injuries and VAERS reports are higher than any other vaccine in its history, after the mRNA gene therapy injections……crickets.

Something doesn’t smell right.

If the FDA had their way we’d just all die already.

For more:

The FDA has a long & sordid history of attempting to ban anything it views as competition to its lucrative drugs & vaccines due to its vested interests with Big Pharma.

Category:

Activism, Herbs, Inflammation, Pain Management, Sleep, Supplements, Treatment

The Lyme Puzzle: Interview With Professor Nicole Baumgarth

https://podcast.tickbootcamp.com/episode/8bc4afa1/the-lyme-puzzle-an-interview-with-professor-nicole-baumgarth

Episode 364: The Lyme Puzzle – an interview with Professor Nicole Baumgarth

July, 2023

Introduction

  • In this episode of Tick Boot Camp, our hosts Matt Sabatello and Rich Johannesen had the opportunity to talk with the remarkable Professor Nicole Baumgarth, director of the Lyme and Tick-Borne Diseases Institute at Johns Hopkins University. Baumgarth brings a unique interdisciplinary background in veterinary medicine, immunology, microbiology, and pathology offering fresh insights into the complex world of Lyme disease and tick-borne illnesses.

Lyme Disease Research

  • Baumgarth and her team are investigating why we don’t mount an effective adaptive immune response to Lyme as we do with influenza (the flu).
  • She reveals their interesting finding about how Borrelia may alter the host’s gut microbiome to enhance its survival.
  • Baumgarth and her team are currently investigating why macrophages, immune cells that gobble up pathogens outside of our cells, don’t eat up Lyme bacteria as they do with other bacteria and viruses.
  • They are also investigating the impact Lyme has on obliterating our lymph nodes, which are critical agents in receiving signals from our body and mounting a specified immune response with targeted B cells and T cells against things like Lyme disease, as well as deploying long term memory immune cells and plasma cells which would give us long-term immunity to Lyme.
  • The Lyme and Tick-Borne Diseases Institute is focusing on investigating why mice get infected with Lyme, the infection persists, yet they never get sick from the infection.
  • If the team can identify human immune system deficits causing any of the above, they could identify immune therapies to overcome these shortcomings and treat all stages of Lyme disease.
  • Baumgarth and her team are also looking into the impact of tick-borne co-infections. They argue that it’s critical to study these diseases together rather than in isolation.

Autoimmune Responses and Lyme Disease

  • Professor Baumgarth suggests that Lyme disease may cause an autoimmune response, which can be particularly concerning for those with genetic predispositions to autoimmunity.
  • She cites several studies, both in the human model and mouse model, proving that Lyme disease creates an unnecessary increase in other antibodies from our immune system that aren’t Lyme-related, resulting in an autoimmunity phenomenon, increased inflammation, and potential immune system burnout.

Understanding Lyme Disease: A Veterinary Perspective

  • Professor Baumgarth’s veterinary background has allowed her to approach Lyme disease from a macro perspective. She emphasizes that Lyme, being a zoonotic disease, is fundamentally an infection that moves from animals to humans.
  • Lyme disease is often a natural infection in animals such as small rodents and birds, where ticks can bite them and transmit the disease.

Investigating the Human Immune Response to Lyme Disease

  • Our hosts discuss how humans’ immune responses to Lyme vary significantly. Some people are bitten by ticks multiple times without falling ill, while others suffer from chronic Lyme after just one bite.
  • This discrepancy might be due to factors such as genetic predispositions, environmental stresses, or an individual’s microbial load.

The Complexity of Eradicating Lyme

  • Eliminating Lyme is not as simple as wiping out a certain animal species, as the bacteria Borrelia can infect a variety of different rodents and even birds.
  • Borrelia is a complex bacterium that replicates slowly and requires a tick to infect a host. It’s constantly evolving and it’s not a simple task to eradicate Lyme from our ecology.

The Role of Antibiotics and Their Impact

  • Despite their potential long-term impact on our immune response, antibiotics are currently the most common form of treatment as soon as Lyme disease is diagnosed. Professor Baumgarth emphasizes a variety of risks when using antibiotics to treat Lyme disease.
  • While antibiotics can help in the short term, their effect on our long-term immunity to future infections is still unclear and Professor Baumgarth strongly warns against prolonged use of antibiotics.

Final Thoughts

  • Baumgarth is hopeful about the future of Lyme disease research. Despite the challenges and controversies, she believes that continued progress is possible with dedicated research and interdisciplinary collaboration.

Episode Wrap-up

  • Professor Nicole Baumgarth’s interview provides an enlightening look into the intricate world of Lyme disease and its complex interaction with our immune system. Her unique veterinary perspective coupled with her background in immunology, microbiology, and pathology as well as her research findings shed light on the challenges we face and offer hope for future breakthroughs in the fight against Lyme and tick-borne diseases.

__________________

**Comment**

My husband and I probably would not be on planet earth without long-term antibiotics so I’m glad this researcher didn’t treat us.  She’s just touting the safe narrative that is expected of academics working in research institutions that get their bread and butter from government grants with many strings attached, controlled by agencies that are completely corrupt.

Nobody denies the risk of prolonged use of antibiotics; however, Lyme/MSIDS can kill you in a myriad of ways.  This never seems to be discussed in the same sentence as prolonged antibiotics.  We would all love a safe, effective, affordable treatment.  Why aren’t researchers looking into this?  I’ll answer you: there’s no money in it, and it doesn’t fit with their narrative for a lucrative cash cow in a Lyme “vaccine.”  

It’s easy to be an arm-chair quarterback when it isn’t your neck on the chopping block.  All I can say is, whatever your opinions are about antibiotics before contracting Lyme/MSIDS, I guarantee they will change as you trod this pot-holed riddled, devastating path.  I hadn’t used antibiotics for 20 years before becoming infected.  I would use ANYTHING but antibiotics.  After I got infected I literally bathed in them for years.  I’m not proud of this, but they worked for both my husband and I, and many others.

It takes savvy to treat this complex illness and while anti-microbials are a MUST, there are many other important treatments required.  Please see the first link below for many treatments that experienced LLMDs have used with success.

For more:

Category:

Lyme, research, Treatment

NIH Funds PTLDS Research: More Deception?

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

NIH awards will fund Post-Treatment Lyme Disease Syndrome research

Carl Tuttle

Hudson, NH, United States

JUL 31, 2023 — 

We are DONE with the JUNK SCIENCE previously financed by the CDC and NIH. Is this yet another deceptive attempt to avoid chronic Lyme disease and make it look as if our public health officials are listening to the disabled Lyme patient community?

Before we start focusing on persistent symptoms, we need to first rule out ongoing infection/co-infections and understand how Lyme disease disables its victim.  Then we need find a cure for all stages of disease.

It is time we get on the bandwagon here and make sure this is not another big waist of time and taxpayer dollars. Please contact Dr. Hugh Auchincloss, Acting NIAID Director and respectfully demand an answer to my inquiry below:

Contact info:

Dr. Hugh Auchincloss    Hugh.Auchincloss@nih.hhs.gov
Sherri DePollar Staff Assistant  Sherri.Depollar@nih.hhs.gov

Image of Dr. Auchincloss was found here:

https://www.niaid.nih.gov/sites/default/files/styles/image_style_33_width_xs/public/Auchincloss-Hugh.jpg?itok=35FyZGfW

Email to Dr. Auchincloss with Cc: to the five researchers receiving grants:

——— Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Hugh.Auchincloss@nih.hhs.gov” <Hugh.Auchincloss@nih.hhs.gov>
Cc: “bjutras@vt.edu” <bjutras@vt.edu>, “mtal@mit.edu” <mtal@mit.edu>, “linden.hu@tufts.edu” <linden.hu@tufts.edu>, “jaucott2@jhmi.edu” <jaucott2@jhmi.edu>, “nwoodbury@asu.edu” <nwoodbury@asu.edu>
Date: 07/30/2023 9:37 AM EDT
Subject: NIH awards will fund Post-Treatment Lyme Disease Syndrome research

NIH awards will fund Post-Treatment Lyme Disease Syndrome research
https://www.nih.gov/news-events/news-releases/nih-awards-will-fund-post-treatment-lyme-disease-syndrome-research

“The new NIAID awards for PTLDS, which will total approximately $3.2 million in first-year funding, will support work on possible causes of persistent PTLDS symptoms for five years.”

July 30, 2023

National Institute of Allergy and Infectious Diseases (NIAID)
5601 Fishers Lane
Rockville, MD 20892
Attn: Hugh Auchincloss, M.D., Acting NIAID Director

Dear Dr. Auchincloss,

In reference to the five grants looking into “Post-Treatment Lyme Disease Syndrome,” what diagnostic methods are you recommending to rule out ongoing infection and or coinfection(s) with other tick-borne diseases in the Lyme disease patient population expected to be evaluated in these five studies?

This step is crucial as evidence of persistent infection despite the CDC’s claim that chronic Lyme does not exist has been suppressed for decades.

For example:

I would like to call attention to the following study recently identifying chronic Lyme disease in twelve patients from Canada.

1. Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease
http://www.mdpi.com/2227-9032/6/2/33

All patients were culture positive for infection (genital secretions, skin and blood) even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

2. In 1991 B. burgdorferi had been isolated in culture from Vicki Logan’s CSF (CDC’s laboratory in Fort Collins CO.) despite prior treatment with 21 days of IV cefotaxime and 4 months of oral minocycline as identified in the following letter to past CDC Director Barbara Fitzgerald: (culture report included)

Letter to CDC Director Barbara Fitzgerald (personal Dropbox storage area)
https://www.dropbox.com/s/xaul84dqmqgbre0/Brenda%20Fitzgerald%20MD%20Director%20CDC.docx?dl=0

3. Per the following 1995 publication, the patient received thirteen spinal taps, multiple courses of IV and oral meds, and relapsed after each one, proven by CSF antigens and/or PCR. The only way this patient (said to be a physician) remained in remission was to keep her on open ended clarithromycin- was on it for 22 months by the time of publication.

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104

Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.

And then there is this recent announcement:

Paralyzed by Lyme, they were helped with combo treatments [long-term antibiotics]
https://www.lymedisease.org/remission-from-lyme-paralysis/

So once again Dr. Auchincloss I ask the question:

What diagnostic methods are you recommending to rule out ongoing infection and or coinfection(s) with other tick-borne diseases in the Lyme disease patient population expected to be evaluated in these five studies? (Or is this step strictly prohibited as a condition of accepting grant money from the NIH?)

Any study that does not rule out active infection is disingenuous.

A response to this serious inquiry is requested.

Respectfully submitted,
Carl Tuttle
Independent Researcher
Hudson, NH

Cc:
Brandon Jutras, Ph.D. Grant: 1 R01 AI178711-01
Michal Tal, Ph.D. Grant: 1 R01 AI178713-01
Linden Hu, M.D. Grant: 1 R01 AI178725-01
John Aucott, M.D. Grant: 1 R01 AI178726-01
Neal Woodbury, Ph.D. Grant: 1 R01 AI178727-01

________________

For more:

Category:

Activism, Lyme, Uncategorized